Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
What causes the selective degeneration of nigrostriatal dopaminergic neurons in the brains of Parkinson's disease patients? As Haass and Kahle explain in their Perspective, a clue comes from new work showing that two proteins implicated in PD (parkin and a-synuclein) normally interact in healthy neurons (Shimura et al.). The Perspective authors speculate that defective targeting of a-synuclein for degradation by parkin results in accumulation of toxic a-synuclein aggregates that selectively kill dopaminergic neurons.
The authors are in the Laboratory for Alzheimer's and Parkinson's Disease Research, Department of Biochemistry, Ludwig Maximilians University, 80336 Munich, Germany.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
RESEARCH ARTICLES
Hideki Shimura, Michael G. Schlossmacher, Nobutaka Hattori, Matthew P. Frosch, Alexander Trockenbacher, Rainer Schneider, Yoshikuni Mizuno, Kenneth S. Kosik, and Dennis J. Selkoe (13 July 2001) Science293 (5528), 263.
[DOI: 10.1126/science.1060627] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets..
M. D. Lopez-Avalos, V. F. Duvivier-Kali, G. Xu, S. Bonner-Weir, A. Sharma, and G. C. Weir (2006)
Diabetes
55, 1223-1231
|Abstract »|Full Text »|PDF »
Parkin-positive autosomal recessive juvenile parkinsonism with {alpha}-synuclein-positive inclusions.
S. Sasaki, A. Shirata, K. Yamane, and M. Iwata (2004)
Neurology
63, 678-682
|Abstract »|Full Text »|PDF »
The Cellular Protein Level of Parkin Is Regulated by Its Ubiquitin-like Domain.
N. Finney, F. Walther, P.-Y. Mantel, D. Stauffer, G. Rovelli, and K. K. Dev (2003)
J. Biol. Chem.
278, 16054-16058
|Abstract »|Full Text »|PDF »
The genetic basis of Parkinson's disease.
T Foltynie, S Sawcer, C Brayne, and R A Barker (2002)
J. Neurol. Neurosurg. Psychiatry
73, 363-370
|Abstract »|Full Text »|PDF »
Caspase-mediated Parkin Cleavage in Apoptotic Cell Death.
S. Kahns, S. Lykkebo, L. D. Jakobsen, M. S. Nielsen, and P. H. Jensen (2002)
J. Biol. Chem.
277, 15303-15308
|Abstract »|Full Text »|PDF »
Idiopathic Rapid Eye Movement Sleep Behavior Disorder Is a Harbinger of Dementia with Lewy Bodies.
R. S. Turner (2002)
J Geriatr Psychiatry Neurol
15, 195-199
|Abstract »|PDF »
Breakthrough in Understanding the Pathogenesis of Parkinson's Disease.
(2001)
Journal Watch Psychiatry
2001, 9
|Full Text »
Breakthrough in Understanding the Pathogenesis of Parkinson's Disease.
(2001)
Journal Watch (General)
2001, 5
|Full Text »